2015 signals more muted public appetite for medtech
This article was originally published in Clinica
2015 saw a drop in IPO activity for medtech, with Clinica recording 27 completed IPOs this year to date, compared to 36 in 2014. Eight IPOs filed this year were still pending, while three companies shelved their plans altogether, all citing inclement market conditions as a reason.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.